Week 3 Exhaustive Academic Notes: The Pharmacist, Pharmacy Profession, and Patient Care Models

Evolution of Pharmacy Practice in the Twentieth and Twenty-First Centuries

  • Pre-1940s Practice Landscape

    • Pharmacy was primarily an occupation where practitioners were trained through apprenticeship.
    • Patent medicines were the norm; many were ineffective, mislabeled, and unsafe, containing secret ingredients and unproven claims to cure a wide range of ailments.
    • No legal standards or regulations existed regarding the safety of therapeutic agents.
    • Drugs were not categorized into prescription and non-prescription classes.
    • Pharmacists served as the primary, first-line source of healthcare advice and medication recommendations for the public.
  • Early Legislative Standards

    • Pure Food and Drug Act of 19061906:
    • First major legislation governing medication use in the United States.
    • Prohibited interstate commerce of misbranded or adulterated food and drugs.
    • Required food and drugs to meet standards of strength, quality, and purity established in The United States Pharmacopoeia and the National Formulary (any deviations had to be stated on the label).
    • Established the foundation for the Food and Drug Administration (FDA), initially known as the Bureau of Chemistry, to enforce standards.
    • Contained significant loopholes and did not address drug efficacy.
    • Food, Drug, and Cosmetic Act of 19381938:
    • Spurred by the 19371937 Elixir Sulfanilamide disaster, which caused over 100100 deaths (many of them children) due to the ingestion of an untested toxic liquid formulation containing a chemical analog of antifreeze.
    • Greatly expanded FDA authority.
    • Mandated that new drugs be proven safe prior to marketing and labeled with directions for safe use.
    • Brought cosmetics and medical devices under FDA oversight.
    • Enforced standards for food quality and safety and authorized factory inspections by the FDA.
  • The Era of Expansion (1940s1940\text{s}–1970s1970\text{s})

    • Hospital Survey and Construction Act of 19461946 (Hill-Burton Act):
    • Provided federal funding for hospital and healthcare facility construction and renovation, targeting underserved urban and rural areas.
    • Mandated that funded facilities provide a reasonable volume of free or uncompensated services to individuals unable to pay.
    • Durham-Humphrey Amendment of 19511951:
    • Amended the Food, Drug, and Cosmetic Act of 19381938 to establish explicit categories for prescription (legend) and non-prescription (over-the-counter) drugs.
    • Mandated that prescription drugs carry the label: "Caution: Federal law prohibits dispensing without a prescription."
    • Social Security Amendments of 19651965:
    • Created Medicare and Medicaid, significantly expanding health coverage and driving a sharp rise in healthcare utilization and pharmaceutical demand.
    • Shift in Pharmacist Role and Education:
    • Advancements in technology and rising demand led to the growth of large-scale pharmaceutical manufacturing.
    • Pharmacists transitioned away from traditional compounding of medicinal products to dispensing prefabricated drug products, leading to a diminished clinical role.
    • The Bachelor of Science (BS) in Pharmacy degree expanded from a 4-year4\text{-year} to a 5-year5\text{-year} program with increased coursework in the physical and biological sciences.
    • Hepler and Strand later described pharmacists during this era as becoming over-educated and underutilized.
  • Modern Era (1970s1970\text{s}–Present)

    • Economic Drivers:
    • Healthcare costs escalated rapidly due to medication and technological advancements, medicalization (defining non-medical human conditions as medical diseases requiring treatment), and fee-for-service insurance structures that incentivized high service utilization.
    • Health Maintenance Organizations (HMO) Act of 19731973:
    • Provided a regulatory framework for developing alternatives to traditional fee-for-service health insurance to deliver cost-effective, quality care.
    • Diagnosis-Related Groups (DRGs):
    • Implemented a taxonomy of disease states and conditions for hospital admissions as a prospective payment system for hospital reimbursement.
    • Unintended consequence: Incentivized hospitals to discharge patients "quicker and sicker" to reduce length of stay and contain operational costs.

Professional Audits, Reports, and Clinical Movements

  • Landmark Profession Audits and Studies

    • Mirror to Hospital Pharmacy (19641964):
    • A national audit of pharmaceutical services in hospitals.
    • Concluded that pharmacy had lost its way in producing professionals and provided recommendations to enhance hospital pharmacy practice development.
    • Dichter Institute Study (19731973):
    • Survey commissioned by the American Pharmacists Association (APhA).
    • Revealed that the majority of the public viewed pharmacists as commercial business people rather than healthcare providers.
    • Millis Commission Report (19751975):
    • Titled Pharmacists for the Future: The Report of the Study Commission on Pharmacy.
    • Found pharmacists inadequately prepared in systems analysis, management skills, and communication skills.
    • Recommended incorporating behavioral and social sciences into pharmacy curricula.
    • Identified internal professional shortcomings resulting from large multi-service pharmacies deemphasizing expertise and patient care.
  • The Clinical Pharmacy Movement

    • Rebranded pharmacists as therapeutic advisors.
    • Introduced the 6-year6\text{-year} Doctor of Pharmacy (PharmD) degree, which ultimately replaced the Bachelor of Science degree as the sole entry-level professional degree.

Pharmaceutical Care, MTM, and Provider Status

  • Pharmaceutical Care

    • Definition: The responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life.
    • Four Primary Outcomes:
    1. Cure of disease.
    2. Elimination or reduction of symptoms.
    3. Arresting or slowing of a disease process.
    4. Prevention of a disease or symptoms.
    • Concept popularized by Linda Strand and Douglas Hepler.
    • Eight Categories of Drug-Related Problems (DRPs) (Strand et al.):
    1. Untreated indications.
    2. Improper drug selection.
    3. Subtherapeutic dosage.
    4. Failure to receive drugs.
    5. Overdosage.
    6. Adverse drug reactions.
    7. Drug interactions.
    8. Drug use without indications.
    • Basic Functions: Pharmacists collaborate with patients and healthcare providers to design, implement, and monitor therapeutic plans by identifying, resolving, and preventing potential or actual DRPs.
  • Barriers to Implementing Pharmaceutical Care

    • Drug Product Focus: Longstanding professional legacy centered exclusively on dispensing activities.
    • Service Focus: Important pharmacist care services remain invisible or unknown to patients.
    • Interprofessional Barriers: Turf wars with physicians, nurses, and other health professionals (e.g., initial opposition to pharmacist-administered immunizations).
    • Lack of Incentives: Compensation systems historical preference for dispensing volume over direct care services.
    • Logistical Barriers: Pharmacy physical layouts historically designed for distribution rather than private patient consultations.
    • Pharmacy Ignorance/Inertia: Lack of broad professional buy-in and resistance to practice change.
  • Medication Therapy Management (MTM)

    • Evolved from pharmaceutical care into a collaborative, proactive approach to optimize therapeutic benefits, facilitate adherence, provide education, and manage disease states.
    • Medicare Prescription Drug, Improvement, and Modernization Act of 20032003:
    • Established Medicare Part D.
    • Mandated provision of and reimbursement for MTM services provided to targeted beneficiaries with multiple chronic conditions, complex drug regimens, and high predicted annual prescription costs.
    • Core Elements of MTM Model (Developed by 1111 national pharmacy organizations):
    1. Medication Therapy Review (MTR): Patient interview, database creation, comprehensive review for indication, efficacy, safety, and adherence, prioritization of DRPs, and action planning.
    2. Interventions and Referrals: Direct collaboration with physicians/providers or referral to appropriate care providers.
    3. Implementation: Creation of a Personal Medication Record (PMR) and Medication-related Action Plan (MAP).
    4. Documentation and Follow-up: Systematic logging of care provided and scheduling targeted follow-up.
  • Reimbursement and Provider Status

    • According to the National Alliance of State Pharmacy Associations (NASPA), 3232 states have passed legislation regarding payment for pharmacist care services or recognizing pharmacists as healthcare providers.
    • Pharmacists currently lack federal provider status recognition under Medicare.

Educational Pathways, Post-Graduate Training, and Certification

  • Pharmacy Curricular Evolution

    • Transitioned to the universal PharmD degree.
    • Integrates health policy, healthcare organization, interprofessional education, communication, economic analysis, cultural diversity, and critical thinking/problem-solving skills.
  • Licensure Requirements

    • Graduation with an accredited PharmD degree.
    • Documented internship hours (~15001500\,hours, dependent on state board regulations).
    • Passing the North American Pharmacist Licensure Examination (NAPLEX).
    • Passing the Multistate Pharmacy Jurisprudence Examination (MPJE) or state-specific equivalent law exam.
  • Postgraduate Training and Certification

    • Residencies: Directed, organized postgraduate training programs in pharmacy practice.
    • PGY-1 (Postgraduate Year One): 1-year1\text{-year} program building general competencies in medication therapy management.
    • PGY-2 (Postgraduate Year Two): 1-year1\text{-year} specialized program following PGY-1 completion. Specialty tracks include: ambulatory care, cardiology, critical care, emergency medicine, geriatrics, infectious diseases, internal medicine, nephrology, neurology, nutrition, oncology, palliative care/pain management, pediatrics, psychiatry, and solid organ transplant.
    • Fellowships: Directed, highly individualized postgraduate training designed to prepare pharmacists to serve as independent research investigators.
    • Board Certification: Optional specialty credentialing that does not expand legal scope of practice but opens advanced clinical roles. Requires licensure, practice experience (residency or documented practice hours), and passing a specialty exam.
    • 1515 Recognized Board Specialties: Ambulatory care, cardiology, compounded sterile preparations, critical care, emergency medicine, geriatrics, infectious diseases, nuclear pharmacy, nutrition support, oncology, pain management, pediatrics, pharmacotherapy, psychiatry, and solid organ transplant.

Pharmacy Workforce, Technicians, and Health Technology

  • Pharmacy Technicians

    • Role: Assist pharmacists with medication preparation, customer service, insurance claim processing, inventory management, cash register operations, and administrative functions, thereby freeing pharmacists for direct patient care.
    • Workforce Statistics (20242024 BLS Data): 490,400490,400 total jobs; median hourly wage of \text{\\$20.90 per hour}.
    • Certification Standards: Requires completion of a Pharmacy Technician Certification Board (PTCB) recognized training program or ge500\\ge 500\,hours of equivalent work experience, passing the Pharmacy Technician Certification Exam (PTCE), and renewing certification every 2-years2\text{-years} with 2020\,hours of continuing education (CE).
  • Health Technology Advances

    • Telehealth Growth: Physician office telehealth adoption surged from 15%15\% pre-pandemic to >80%>80\% between 20192019 and 20212021. Global market projected to expand from >\text{\\$35 billion} in 20242024 to >\text{\\$160 billion} by 20342034.
    • E-Prescribing: Implemented in 20052005; by 20212021, 94%94\% of prescriptions in the US were transmitted electronically.
    • Artificial Intelligence: Used to streamline drug discovery, optimize development pipelines, and enhance decision-making.
    • Digital Adherence Tools: Telepharmacy, digital health apps, automated SMS reminders, virtual pillboxes, and smart pill bottles.
  • Pharmacist Workforce Trends

    • 20242024–20342034 Projections (Bureau of Labor Statistics): 335,000335,000 jobs in 20242024, expanding to 350,000350,000 jobs by 20342034 (5%5\% growth rate).
    • Driven by continuous growth in annual prescription volume, an aging population, and expanding MTM/clinical service obligations.

Demographics, Internet Access, and Health Information

  • US Demographic Trends

    • Population Aging (65+65+): Increased by 34%34\% between 20122012 and 20222022. Totaled 61.2 million61.2\text{ million} (18%18\% of population; 1 in 61\text{ in }6 Americans) in 20242024; projected to reach 78 million78\text{ million} (22%22\%) by 2040$.\n * **Oldest-Old Segment (85+)∗∗:Fastest−growingdemographicsegment.Countedat)**: Fastest-growing demographic segment. Counted at6.3\text{ million}((1.9\%)inthe) in the2020census;projectedtoreachcensus; projected to reach13.7\text{ million}byby2040$.
    • Chronic Disease Shift: Medical advancements have shifted primary health challenges from acute infectious illnesses to long-term chronic condition management.
    • Healthy People Initiative: Decennial national prevention guidelines published by the US Department of Health and Human Services since 19801980 (Current iteration: Healthy People 2030).
  • Internet Information and Digital Divide

    • Internet Adoption: 97%97\% of US adults access the internet; however, 26 million26\text{ million} Americans lack access to high-speed broadband (BroadbandNow June 20252025 audit data).
    • Online Health Searching: 58.5%58.5\% of adults seek medical, drug, or test information online (National Health Interview Survey).
    • Age Metrics: Adults aged 3030\text{--}4040 demonstrate the highest rate of communicating with doctors online (47.7%47.7\%).

Models of Practitioner-Patient Relationships

  • Szasz and Hollander Models (1950s1950\text{s})

    • Activity-Passivity: Active provider, completely passive recipient. Comparable to parent-infant relationship. Applied in emergency or comatose care situations.
    • Guidance-Cooperation: Patient listens and follows advice, deferring to professional expertise. Comparable to parent-adolescent relationship. Applied in acute infection or injury management.
    • Mutual Participation: Equal power dynamic, interdependent collaboration. Comparable to adult-adult relationship. Essential for long-term chronic disease management.
  • Alternative Practice Models

    • Consumer Model: Customer-focused framework treating the patient as an informed buyer with rights and the practitioner as a seller with obligations. Criticized for escalating mistrust and devaluing specialized medical knowledge.
    • Patient-Centered Model: Replaces traditional disease-centered focus with whole-person care. Evaluated using 44 core elements:
    1. Eliciting patient's ideas regarding cause of illness.
    2. Exploring emotional feelings about the illness.
    3. Assessing the impact of illness on daily functional life.
    4. Clarifying patient expectations regarding treatment options.
    • Biopsychosocial Model: Integrates physical, psychological, emotional, and social parameters into care evaluation, replacing rigid biochemical disease paradigms.

Adherence, Health Literacy, and Communication Strategies

  • Compliance vs. Adherence

    • Compliance: Passive, paternalistic model where the patient follows instructions given by an authoritative provider.
    • Adherence: Autonomous model where the patient actively agrees to a mutually negotiated treatment plan. Standard research threshold defined as ≥80%\ge 80\% medication intake.
    • Adherence Measurement Methods:
    • Direct: Direct observation, drug metabolite/biochemical tests in blood or urine.
    • Indirect: Self-reporting, standardized questionnaires, pill counts, electronic bottle monitors, prescription refilling history.
    • Non-Adherence Patterns:
    • Primary: Failure to fill or obtain the initial prescription.
    • Secondary: Filling the prescription but failing to take it correctly as prescribed.
    • Prevalence: World Health Organization estimates 50%50\% non-adherence among chronic disease patients (general studies report ranges of 36%36\% to 76%76\%).
  • ACCP Determinants of Adherence (55 Key Domains)

    1. Health system factors (provider communication, access to care).
    2. Social and economic factors (cost, living environment, support networks).
    3. Condition-related factors (symptom severity, disability level, comorbidities).
    4. Patient-related factors (beliefs, self-efficacy, cultural views, expectations).
    5. Therapy-related factors (regimen complexity, adverse effects, delay in benefits).
  • Health Literacy and Communication

    • Healthy People 20302030 Definitions:
    • Personal Health Literacy: Ability to locate, understand, and apply health information for personal decision-making.
    • Organizational Health Literacy: Degree to which institutions equitably enable individuals to locate, understand, and use health information.
    • National Assessment of Adult Literacy (20032003 NAAL Data):
    • 12%12\% Proficient
    • 53%53\% Intermediate
    • 21%21\% Basic
    • 14%14\% Below Basic
    • Communication Best Practices:
    • Communicate health information at a 5th-grade level5\text{th}\text{-grade level}.
    • Limit oral delivery to 11\text{--}33 key points.
    • Use open-ended questions, visual aids, clear written summaries, and plain non-medical language.
    • Employ the Teach-Back Technique (asking patients to state the therapeutic instructions in their own words to confirm comprehension).

Health Behavior Theories and Behavioral Interventions

  • Locus of Control (Rotter)

    • Evaluates whether individuals attribute outcomes to internal actions or external environment.
    • External locus split into Powerful Others (providers, family) or Chance/Luck.
  • Health Belief Model

    • Predicts behavioral change based on perceived susceptibility and perceived severity of disease (establishing Perceived Threat).
    • Perceived threat is weighed against Perceived Benefits vs. Perceived Barriers (cost, time, effort).
  • Social Cognitive Theory / Self-Efficacy

    • Differentiates Outcome Expectations (belief that action leads to specific results) from Efficacy Expectations (belief in personal ability to execute the action).
    • Sources of self-efficacy: Performance accomplishments (past success), vicarious experiences (observing peers), verbal persuasion, and physical/emotional states.
  • Theory of Reasoned Action and Planned Behavior

    • Reasoned Action: Intention drives behavior; shaped by personal attitude toward behavior and subjective social norms.
    • Planned Behavior: Adds the dimension of Perceived Behavioral Control (skills, money, time, resources, willpower).
  • Transtheoretical Model of Change (Stages of Change)

    1. Precontemplation: No intention to alter behavior within 6 months6\text{ months}.
    2. Contemplation: Considering change within 6 months6\text{ months}; weighing pros and cons.
    3. Preparation: Intending to take concrete action within 1 month1\text{ month}.
    4. Action: Active implementation of behavioral modifications (<6 months<6\text{ months}).
    5. Maintenance: Sustaining behavior long-term and preventing relapse (6 months6\text{ months} to 5 years5\text{ years}).
  • Ten Processes of Change

    • Consciousness raising: Increasing awareness of behavior risks.
    • Emotional arousal: Experiencing affective feelings regarding habits.
    • Self-reevaluation: Re-assessing identity with new behaviors.
    • Environmental reevaluation: Assessing behavioral impacts on social circles.
    • Self-liberation: Committing to action.
    • Counter conditioning: Substituting healthy habits for bad ones.
    • Stimulus control: Managing environmental cues.
    • Contingency management: Rewarding positive change.
    • Helping relationships: Utilizing social support.
  • Motivational Interviewing (MI) Principles

    • Expressing Empathy: Using reflective listening to build trust.
    • Developing Discrepancy: Highlighting gap between current actions and core goals.
    • Rolling with Resistance: Avoiding direct confrontation; shifting communication strategy.
    • Avoiding Argumentation: Preventing defensive responses.
    • Supporting Self-Efficacy: Reinforcing patient confidence and capability.